BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.771
EU - Europa 5.875
AS - Asia 4.742
SA - Sud America 652
AF - Africa 125
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 23.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.623
GB - Regno Unito 1.948
IT - Italia 1.779
CN - Cina 1.303
SG - Singapore 1.241
HK - Hong Kong 635
VN - Vietnam 505
BR - Brasile 477
SE - Svezia 438
DE - Germania 339
TR - Turchia 275
UA - Ucraina 240
FI - Finlandia 232
RU - Federazione Russa 224
FR - Francia 216
IN - India 171
KR - Corea 161
BG - Bulgaria 88
NL - Olanda 73
CA - Canada 63
AR - Argentina 62
IQ - Iraq 50
MX - Messico 50
BD - Bangladesh 49
JP - Giappone 49
IE - Irlanda 47
ID - Indonesia 46
ES - Italia 39
PK - Pakistan 36
PL - Polonia 34
IR - Iran 33
ZA - Sudafrica 33
CO - Colombia 29
BE - Belgio 28
RO - Romania 28
AE - Emirati Arabi Uniti 26
EC - Ecuador 21
CH - Svizzera 17
EG - Egitto 17
IL - Israele 17
CL - Cile 16
UZ - Uzbekistan 16
AU - Australia 15
DZ - Algeria 15
LT - Lituania 15
MA - Marocco 14
MY - Malesia 14
SA - Arabia Saudita 14
VE - Venezuela 14
GR - Grecia 13
CZ - Repubblica Ceca 12
JO - Giordania 12
PY - Paraguay 12
PT - Portogallo 11
KE - Kenya 10
KZ - Kazakistan 10
TN - Tunisia 10
TW - Taiwan 10
EU - Europa 9
PH - Filippine 9
AZ - Azerbaigian 8
RS - Serbia 8
AT - Austria 7
CR - Costa Rica 7
HU - Ungheria 7
PE - Perù 7
UY - Uruguay 7
BO - Bolivia 6
DK - Danimarca 6
NP - Nepal 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
NO - Norvegia 5
OM - Oman 5
AL - Albania 4
BZ - Belize 4
EE - Estonia 4
HN - Honduras 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
PR - Porto Rico 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
GH - Ghana 2
Totale 23.169
Salva come PNG Salva come JPEG
Città #
Southend 1.526
Ashburn 1.095
Fairfield 1.079
Santa Clara 1.007
Singapore 768
Woodbridge 706
Chandler 649
Hong Kong 627
Houston 458
Jacksonville 457
Seattle 445
Wilmington 444
Chicago 418
Dearborn 387
Ann Arbor 379
Cambridge 367
Hefei 331
Beijing 324
Nyköping 282
San Jose 275
Modena 236
London 229
Los Angeles 228
Ho Chi Minh City 176
Izmir 158
Helsinki 146
The Dalles 131
Seoul 117
Council Bluffs 116
New York 101
Salt Lake City 98
Hanoi 92
Princeton 91
Milan 90
San Diego 83
Sofia 83
Eugene 80
Rome 77
Lauterbourg 62
Moscow 58
Dallas 57
Bologna 54
Redwood City 53
Buffalo 50
Fremont 48
Elk Grove Village 47
Falls Church 47
São Paulo 46
Shanghai 45
Tampa 44
Orem 42
Tokyo 41
Chennai 38
Munich 36
Bremen 35
Phoenix 35
Dublin 33
Frankfurt am Main 33
Columbus 32
Jakarta 28
Como 27
Napoli 26
Brussels 24
Des Moines 24
Guangzhou 24
Naples 24
Reggio Emilia 23
Florence 22
Lancaster 22
San Giuliano Milanese 22
Da Nang 21
Tulare 21
Sterling 18
Warsaw 18
Baghdad 17
Boardman 17
Manchester 17
Mexico City 17
Palermo 17
Johannesburg 16
Miami 16
Montreal 16
Norwalk 16
Stockholm 16
Brooklyn 15
Kocaeli 15
Nanjing 15
New Delhi 15
Genoa 14
Perugia 14
Atlanta 13
Bari 13
Biên Hòa 13
Cairo 13
Catania 13
Dulles 13
Haiphong 13
Parma 13
Sydney 13
Tashkent 13
Totale 16.019
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 570
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 501
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 447
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 432
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 418
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 411
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 408
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 406
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 392
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 392
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 383
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 383
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 357
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 356
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 353
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 351
Nanomedicine: the future for advancing medicine and neuroscience 350
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 350
Protein corona and nanoparticles: How can we investigate on? 344
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 343
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 341
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 339
Nanoparticle transport across the blood brain barrier 338
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 337
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 336
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 336
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 324
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 323
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 321
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 318
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 308
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 305
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 301
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 298
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 298
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 298
Functionalization of liposomes: microscopical methods for preformulative screening 294
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 292
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 291
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 291
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 289
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 289
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 284
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 266
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 261
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 258
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 254
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 249
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 249
Immunonanosystems to CNS pathologies: State of the art 248
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 246
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 245
Nanotechnology and Central Nervous System Drug Delivery 239
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 239
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 237
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 236
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 235
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 231
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 228
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 223
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 217
Leptin-conjugated nanoparticles as drug delivery system to the brain 215
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 214
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 214
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 212
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 209
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 206
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 196
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 190
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 188
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 178
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 177
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 172
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 169
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 162
Nanomedicine in neurodegenerative disorders: Understanding the journey 148
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 138
Nanotechnology in medicine: therapeutic strategies in neurological disorders 134
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 128
Totale 23.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021734 0 0 0 0 0 0 0 0 0 494 144 96
2021/20221.693 100 156 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/20253.723 170 54 62 287 765 520 279 307 335 161 354 429
2025/20266.210 436 214 456 876 1.382 473 738 330 698 607 0 0
Totale 23.405